TheraRadar
← Back
Data updated: Mar 29, 2026

LEDERLE

Infectious DiseaseCardiovascularNeurology
Big Pharma

LEDERLE is a major pharmaceutical company focused on Infectious Disease, Cardiovascular, Neurology.

1941
Since
49
Drugs
-
Trials
291
Approved (2yr)

Key Drugs

No active drugs

Top Drug Revenues Pro

Loading...

Revenue Over Time Pro

Loading...

Recent Activity

PROPRANOLOL HYDROCHLORIDE 2026-01-27
CHLORPROMAZINE HYDROCHLORIDE 2026-01-26
AMITRIPTYLINE HYDROCHLORIDE 2026-01-09
Labeling
ACETAMINOPHEN AND CODEINE PHOSPHATE 2025-12-22
Labeling
ACETAMINOPHEN AND CODEINE PHOSPHATE 2025-12-22
Labeling
ACETAMINOPHEN AND CODEINE PHOSPHATE 2025-12-22
Labeling
ACETAMINOPHEN AND CODEINE PHOSPHATE 2025-12-22
Labeling
ACETAMINOPHEN AND CODEINE PHOSPHATE 2025-12-22
Labeling
SEC Filings Pro
Loading...

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Infectious Disease 33%
2 drugs
Cardiovascular 17%
1 drugs
Neurology 17%
1 drugs
Dermatology 17%
1 drugs
Respiratory 17%
1 drugs

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...

Competitors by Therapeutic Area

GE HEALTHCARE specialty
Infectious Disease, Neurology, Cardiovascular, Respiratory
APOTHECON specialty
Infectious Disease, Dermatology, Cardiovascular, Respiratory
Baxter specialty
Infectious Disease, Cardiovascular, Dermatology
PAI HOLDINGS PHARM big-pharma
Dermatology, Infectious Disease, Neurology, Cardiovascular
ABBOTT big-pharma
Infectious Disease, Dermatology, Neurology, Respiratory